News

GUIDELINES ON COMPANY PROCEDURES RELATING TO THE 2021 ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY

LEO Pharma, Norgine, Daiichi-Sankyo, Novartis, Sanofi, Consilient, and Pharmasure have been named in advertisements for breaches of the ABPI Code

Novartis, Camurus, Pfizer and Boehringer Ingelheim have been named in advertisements for breaches of the ABPI Code

The PMCPA is recruiting ​

Vacancies for independent members of the Code of Practice Appeal Board

New PMCPA Director appointed

Britannia, AstraZeneca, Allergan, GlaxoSmithKline and Sanofi named in advertisements for breaches of the ABPI Code

Leo, Janssen, Teva, Lundbeck, Otsuka Europe, Daiichi-Sankyo, and Roche named in advertisements for breaches of the ABPI Code

PMCPA Deputy Director

Britannia and Vifor (public reprimands), AbbVie, Allergan, Advanced Accelerator Applications (a Novartis company), Otsuka Europe and Otsuka UK (breaches of ABPI Code) named in advertisements

New PMCPA Manager - Maleeha Sultan

Vacancies for independent members of the Code of Practice Appeal Board